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Sonoelastography is a method capable of evaluating the mechanical properties of soft 
tissues by ultrasound (US). A further development of this technique is shear wave 
elastography (SWE), which provides a quantitative evaluation of the elastic properties - in 
terms of tissutal stiffness - by measuring the propagation velocities of the directional shear 
waves, produced by an ultrasound pulse. 
Spasticity often appears in stroke patients in the affected limbs. It corresponds to velocity-
dependent muscle hypertonia in relation to the hyperexcitability of the stretch reflex. Over 
time, the paretic muscles develop intrinsic alterations with consequent muscle shortening 
and increased fibrosis related to reduced use and immobilization.  
Intramuscular injections of botulinum toxin A (BoNT-A) is an effective treatment which 
reduces muscle activity by inhibiting the release of acetylcholine at the neuromuscular 
junction level and is therefore able to reduce neuromediated muscle hypertonicity.  
The study aims to evaluate the effectiveness of SWE to appreciate changes in stiffness in 
spastic muscles after treatment with BoNT-A and possibly detect differences between 
affected muscles and unaffected contralateral ones related to fibrous-fatty remodeling. 
 
 
Materials & Methods 
 
14 adult patients (5F; age: 58,4±14,1 years, m±SD; range:46-78) affected by spasticity were 
recruited after ischemic or hemorrhagic stroke diagnosed for at least 3 months and with a 
time interval from the last injection of at least 4 months, if already treated with BoNT-A. 
They patients underwent a physical examination in which muscle hypertonia was assessed 
using the modified Ashworth scale (MAS). The assessments were carried out on a sample 
muscle among the spastic ones favoring the greater volume and better accessibility to the 
ultrasound probe. SWE was also performed on the homologue non-paretic contralateral 
muscle. Spasticity was measured as the average electromyographic activity recorded during 
stretching (reflex by stretching) of the selected muscle at a reproducible speed, according to 
a previously validated methodology. The SWE evaluation was carried out with US scans 
across and along the direction of muscular fibers - as assessed by conventional US - 
covering the entire belly of the selected muscle to obtain a comprehensive estimate of the 
muscle stiffness both with the maximum shortened and elongated muscle position. Muscle 
fibrosis was also estimated on conventional B-mode US using the modified Heckmatt scale. 
All evaluations were performed shortly before botulinum toxin infiltration (T0) and one 
month later (T1). Clinical, electromyographic and ultrasound evaluation were performed by 
three different blinded examiners. Depending on data distribution, non-parametric statistical 
tests for paired data were performed for comparison; Spearman’s r was calculated to assess 








A total of 224 SWE values resulted considering both time points. Overall, SWE 
measurements on paretic muscles assessed with a longitudinal positioning of the probe 
showed statistically significant reduction at T1 versus T0 both in non stretched conditions 
(p=0.001) and in stretched conditions (p=0.0029). 
After BoNT-A injection, a significant reduction in MAS (p=0.009), spastic dystonia 
(p=0.0043), spasticity (p=0.0019) and longitudinal SWE measurements, both in non 
stretched conditions (p=0.001) and in stretched conditions (p=0.0029),  was observed. No 
significant changes in SWE parameters were observed on non-paretic versus contralateral 
muscle . All SWE measurements were higher in the paretic limb than in the contralateral 
one (p<0.01); higher SWE measurements resulted along the direction of muscular fibers 
versus across them (p<0.01). Cohen’s d estimate a larger effect on EMG values than 
longitudinal SWE ones (either in non stretched and in stretched condition), with narrower 
95%CI for SWE measurements. No changes resulted by the modified Heckmatt scale US 





This is the first study evaluating the effect of BoNT-A on muscle hypertonia following 
stroke, assessed by mean of SWE and compared with the stretch reflex. The treatment 
resulted in a reduction of MAS, stretch reflex and muscular stiffness, in relation to the 
reduction of the neuro-mediated hypertonia. We have therefore shown that SWE is able to 
appreciate a reduction in neuro-mediated stiffness. Abolishing the neuro-mediated 
contribution by keeping the limb in a shortened position and moreover after BoNT-A 
injection, the SWE values resulted higher in the paretic muscle than in the healthy muscle in 
the same position. Hence, SWE-driven comparison between the spastic muscle and the 
contralateral unaffected homologous one is able to disclose the amount of stiffness due only 
to intrinsic muscular involutive remodeling. Alongside sEMG, SWE could therefore 
constitute an added-value to clinicians who manage spasticity for the assessment of 






























List of Abbreviations 
 
ARF - Acoustic Radiation Force 
ARFI - Acoustic Radiation Force Imaging 
ARV - Average Rectified Value 
BoNT-A - Botulinum NeuroToxin-A 
FOV - Field Of View 
KHz - KiloHertz 
Kpa - Kilopascal 
MAS - Modified Ashworth Scale 
MHS - Modified Heckmatt scale 
MHz - MegaHertz 
mm - Millimeters 
MRE - Magnetic Resonance Elastography 
m/s - Meters per second 
ROI - Region Of Interest 
RF - Radiofrequency 
SD - Standard Deviation 
sEMG - Surface Electromyography 
SEL - Sonoelastography 
SWE - Shear Wave Elastography 
THI - Tissue Harmonic Imaging 
UMNS - Upper Motor Neuron Syndrome 
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1. Ultrasound basic principles 
 
 
Ultrasonography (US) is a well-established tomographic technique capable of 
providing a real-time representation of each human body structure, including moving 
structures. US clinical applications are continuously increasing thanks to its high 
sensitivity and image resolution, quickness, safety, portability and cost-effectiveness 
(Silvestri 2015).  
In the past decade US become the referential imaging modality in the first level study 
of the soft-tissue components of the musculoskeletal system. Recent technological 
innovations improved image quality, reducing artefacts, and made possible the 
precise and accurate evaluation of almost all soft-tissue structures. Rapid advances in 
transducer technology (broadband and high definition probes), development of Tissue 
Harmonic Imaging (THI) systems, new dedicated software’s and reconstruction 
algorithms (Compound imaging, Steering-Based imaging, Extended-Field-Of-View 
imaging, Three-Dimensional imaging, Sonoelastography), together with the 
possibility of a dynamic analysis of tendinous and muscular structures, resulted in 
increased diagnostic performances and opened new field of applications in the 
musculoskeletal area of interest.  
In addition, it is important to highlight that US imaging has acquired a central role, 
not only in diagnostic phase, but also as an important guide for therapeutic 
manoeuvres such as biopsies of soft tissues, articular and periarticular infiltrative 
procedures, drainage of fluid collections and muscular haematomas.  
As US examination is relatively operator-dependent, it presumes a good knowledge 
of the physical principles on which it bases on and the technical properties of the 




1.1  Ultrasound wave properties 
Ultrasonography is based on the use of acoustic waves belong to the ultrasounds 
band. Ultrasounds are sounds possessing high frequencies, considerably higher than 
the human hearing range (> 20 kHz). Ultrasound waves propagate in the human body 
thanks to the elastic forces existing between the adjacent molecules of the 
encountered structures, as compression and rarefaction bands. (Fig.1).  
Sound waves are mechanical pressure waves, produced by a disturbance source, that 
induce vibration of the particles of the material. Each particle swing, moving small 
distances from its rest position, so the vibrational energy is propagated from particle 
to particle as a wave travelling through the medium. On the basis of their relationship 
to the propagation direction of energy, sound waves are classified as being 
longitudinal or transverse waves, if the particles vibrate in the same direction or 
perpendicular to the propagation respectively. Longitudinal waves are tipically 
observed in soft tissues and liquids; the compact bone is the only tissue capable of 
supporting transverse sound waves (Silvestri 2015). 
It is important to know the parameters characterizing an ultrasound wave: amplitude, 
frequency, wavelength, period, velocity, power and intensity (Tab. I).  
  
 
Fig. 1 The graphic demonstrates the oscillatory behaviour of the ultrasound waves 




Tab. I  Main parameters that characterize an ultrasound wave. 
 
 
amplitude (A)  
  
the maximum pressure value reached during the compression phase.  
frequency (Υ)  
the number of cycles per unit of time (complete oscillations that each 
particle undergoes each second). Frequencies employed in diagnostic 
ultrasonography range from 1,5 to 20 MHz and sometimes higher. The 
high frequency of ultrasound waves is correlated to a very low 
wavelength; this properties guarantee the production of thin beam, well 
collimated, with a small divergence.  
 
wavelength (λ)  
the spatial interval in which each oscillatory phenomenon is reproduced. 
It is inversely proportional to frequency and influences the spatial 
resolution of the US image: the smaller the wavelength (corresponding 
to high frequency) the higher the spatial resolution; the greater the 
wavelength (corresponding to low frequency) the lower the spatial 
resolution.  
 
period (Ϯ)  
  
the time interval in which each oscillatory phenomenon is reproduced.  
velocity (v)  
depends on the physical properties of the propagation medium. It varies 
in relation with tissue elasticity and density. Acoustic velocity is greater 
in rigid or less compressible materials, such as bone and metals, lower in 
air, water and soft tissues. The mean velocity in soft tissue (excluding 
bone and air) is 1540 m/s, the reference value used by manufacturers in 
the calibration of internal distance measurements.  
 
power (P)  
  
the total amount of energy passing through a surface per unit time 
(Watts).  
intensity (I)  
the strength of an ultrasound wave; it is the energy per unit area per unit 
time (Watts per square centimetre). Intensity changes depending on the 
width of the ultrasound beam; in focused beams it is greatest at the focus 




1.2  Interactions between US and anatomical structures   
In ultrasonography, high-frequency sound waves are generated and transmitted 
through the body by a transducer. When the US beam runs into a tissue target some 
of its energy is reflected back to the transducer, as a returning echo, some is deflected 
and continues its propagation into tissues. The transducer is responsible for both the 
production of the US beam and the detection of the returning echoes; it behave as an 
antenna that converts electrical pulses into the transmitted sound waves and receives 
the reflected and scattered ultrasound waves, converting them back into electrical 
signals, then encoded into images.  
In travelling through the body, a sound wave is subjected to varying phenomena that 
contribute to US image formation: attenuation, absorption, reflection, diffusion, 
refraction and divergence.  
Attenuation: is the continuous loss of acoustic energy (intensity) that the US beam 
undergoes running into tissues. It is usually expressed in units of decibels per 
centimetre and correlated to the US frequency (MHz) and the distance travelled (cm): 
the higher the frequency and the distance, the greater the attenuation. For this reason, 
although high frequency US allow a better image resolution, the US beam is more 
attenuated. This fact has an important practical implication: high- frequency linear-
array probes (7-13 MHz) are used for the study of superficial structures (tendons, 
muscles, ligaments); low-frequency curved-array probes (2,5-5 MHz) are utilized for 
deep organs evaluation. The main causes of attenuation are absorption, reflection, 
refraction, diffusion and divergence.  
Absorption: is the greatest cause of attenuation. The acoustic energy is transferred 
from the US beam to tissues and transformed into heat. The amount of absorption 
depends on US beam frequency and intrinsic characteristics of the medium (low in 
liquids, intermediate in soft tissues, high in bones and air).  




with different acoustic impedance, some of the energy is reflected (reflection) and the 
remainder is transmitted deviated through the interface (refraction), (Fig.1.2). The 
direction of the reflected wave (returning echo) depends on the orientation of sound 
wave relative to the surface: the angle of reflection equals the angle of incidence. The 
amplitude of the echo is directly correlated to: (a) the orientation of the US beam to 
the reflecting surface: reflection is greatest when the US beam is perpendicular to the 
surface (angle of incidence = zero), so produce the strongest detected echoes in 
clinical sonograms (specular reflection); (b) the relative difference in acoustic 
impedance between the tissues on either side of the interface: acoustic impedance is 
an intrinsic property of tissues which expresses their resistance to the passage of the 
US beam (expressed in units of Rayls = kilograms per square meter per second). The 
greater the difference in acoustic impedance between two materials, the stronger will 
be the intensity of the returning echo. Reflection can be either specular or diffuse, 
depending on the interface characteristics. When the interface is represented by a 
wide, smooth and homogeneous surface (diaphragm, vessel wall) the reflection is 
specular or mirror-like; when the interface shows a small, irregular and rough surface 
(parenchymal organs) the reflected wave will be diffuse.  
Diffusion: is the scattering of the reflected US beam in all directions. It is typical of 
the parenchymal tissues, in which sound is scattered by the many cell and tissue 
elements that function as multiple interfaces.  
Refraction: is the deviation of the transmitted beam from the incident beam direction. 
It increases as the angle of incidence is not perpendicular to the surface.  
Divergence: if the US beam is not focused, tends to diverge distally with consequent 






1.3  Image formation  
Ultrasonographic images are obtained with a pulse-echo type of measurement.  
The transducer is an essential element of US equipment’s. It is composed by a 
number of assembled crystals that are excited by electrical pulses (piezoelectric effect 
- applying an electric field to crystals causes their mechanical oscillations). Based on 
the pulse-echo principle occurring with piezoelectric crystals, US transducers convert 
electricity (electrical energy) into sound (mechanical energy).  
The US waves, sent from the transducer, propagate through tissues and then return 
reflected as echoes to the transducer. Those returning echoes are then converted back 
into electrical pulses by the transducer crystals (reverse piezoelectric effect - converts 
mechanical energy, due to crystal deformation, into electrical energy) and are further 











The US beam is considered a combination of multiple thin beams produced by each 
crystal assembled in the transducer, with a linear or curved disposition. Currently, 
transducers contain a range of ultrasound frequencies (bandwidth) instead of a single 
fundamental frequency.  
The generation of US images requires a complicated acquisition and display of 
ultrasound pulse-echo data. The broadband transducer generates a sequential series of 
focused beams all in the same plane (scan plane). Each set of target data from a 
single pulse transmission is placed in the image, as acquired along a line. All tissues 
in the scan plane are interrogated by these beams and each real-time image frame is 
composed of a set of parallel or sector lines representing the positions of the 
interrogating beams in the patient. Computer algorithms are used to fill in between 
the image lines so that the image appears continuous.  
When the transmitted US pulse encounters internal tissue targets, part of its energy is 
deflected (reflected or scattered) back to the transducer (the echo). Because pulse-
echo imaging techniques employ the same transducer for both sending and receiving 
US pulses, only echoes traveling in the direction of the transducer have any chance of 
being detected (Silvestri 2015).  
The main pulse-echo parameters used in the formation of images include echo 
amplitude and target spatial position. Echo amplitude is encoded into shades of grey 
(grey-scale imaging), with the lighter shades representing higher amplitude echoes.  
The depth of the target along the direction of the beam is accurately calculated from a 
pulse time-of-flight measurement. Assuming US propagation velocity is fairly 
constant from tissue to tissue (1540 m/s), the time between beam transmission and 
echo reception is used to determine the exact internal spatial location of all tissue 
targets.  




Spatial resolution refers to the capability to distinguish two adjacent points, along the 
axis of the beam (axial resolution) or in a plane perpendicular to the axis of beam 
(lateral resolution).  
Temporal resolution represents the capability of the US equipment to show 
anatomical structures in real time. It is related with the pulse repetition frequency 
(PRF) and with the frame (number of encoded images per unit time).  
Visualization systems:  
1. Amplitude mode (A-mode): the simplest form of display. It is a diagram in which 
echo amplitude is shown according to tissue depth (echo time of flight).   
2. Time-motion mode (TM-mode): echoes returning from moving structures are 
displayed depending on the time. It is used in cardiac US evaluation.   













1.4  US equipment  
Good technical skills are essential in order to extract the maximum amount of 
information that can be obtained with the equipment, while avoiding the numerous 
pitfalls and artefacts of US imaging modality. Some important parameters can be 
adjusted before and during US examination in order to improve image quality and 
diagnostic performances.  
Probe selection: high-frequency linear-array probes, operating with frequencies of 10 
MHz or more, are mandatory for a precise evaluation of the soft-tissues of the 
musculoskeletal system (Fig. 3).   
 
   
 
Fig. 3.  Linear array probe with frequency range 5-12 MHz (left). Convex array 
probe with lower frequency range 2-5 MHz (right).  
 
Beam focusing: determine the number and pattern of focal zones (zone in which the 
width and thickness of the US beam is reduced in order to increase contrast and 
spatial resolution). The focal depth can be changed dynamically during the 
examination.  




Zoom: better visualize small and thin structures.   
Dynamic range adjustment: set the contrast resolution. High values of the dynamic 
range allows for the visualization of very low-intensity echoes, reducing the contrast 




1.5  Artifacts  
Image artifacts (errors in image display) are common in clinical ultrasonography and 
can cause confusion for the interpreting physician. Some artefacts occur secondary to 
improper scanning technique; others are unavoidable because correlated to the 
physical characteristic of the US beam.  
A detailed description of US artifacts lies outside the aim of this work. However, the 
knowledge of artifacts often encountered in US soft-tissue evaluation is essential to 
improve diagnostic performance.  
Anisotropy is the intrinsic property of some anatomical structures to modify their 
reflecting capability in respect to the US beam angle of incidence. If the US beam not 
perpendicularly encounters linear structures, such as muscles, tendons and ligaments, 
the reflection isn’t specular so the returning echoes have low intensity: the structure 
wrongly appears more hypoechoic (the artifact results with a loss of echogenicity in 
structure). (Fig. 8) The ability to recognize and correct anisotropy artifacts is 






1.6  US of muscles 
Selection of the proper transducer and US parameters are important aspects of muscle 
ultrasonography and depends on the depth and size of the muscle in exam.  
For superficial muscles high-frequency (7–15 MHz) linear transducers are most 
useful and provides a good balance between tissues penetration and resolution; 
however, a correct examination of deeper structures sometimes requires a lower-
frequency convex transducers (3-10 MHz). (Fig. 3) 
US muscles appearance is predominately hypoechoic with hyperechoic septations: 
muscle bundles are hypoechoic in comparison to subcutaneous fat and are separated 




Fig. 4. Extended-field-of- view US scan showing thigh muscles and fasciae 
(arrowheads) appearance. RF, rectus femoris; VL, vastus lateralis; VM, vastus 
medialis; Vi, vastus intermedius; F, femur  
 
In short axis, muscle tissue appears as dots and short lines producing a “starry sky” 
appearance (Fig.5).  




septa, appear as parallel lines that gives rise to fusiform or pennate appearance 
(semipennate, unipennate, bipennate, multipennate).  
 
 
Fig. 5. US scan of the posterior leg showing soleus muscle (SO) internal architecture 
and, superficially, the forming Achille’s tendon (*).  
 
  
Fig. 6. US scan of the thigh showing the tensor fasciae latae muscle (TFL) and its 
aponeurosis (arrowheads). VL, vastus lateralis muscle.  
 
In normal subjects the epimysium surrounding the muscle appears as a highly 
reflective structure; the bone, if visualized, appear as a bright echo, representing the 




The intramuscular tendon and the aponeurosis appears as highly hyperechoic linear 
structures within the muscle; the musculotendinous junction, which varies in size 
from muscle to muscle, is seen as a hyperechoic fibrillar structure merging with the 
muscle belly (Fig. 6 and Fig. 7). The fascia appears as a brightly echogenic fibrillar 
structure that delineates the muscle from subcutaneous tissue and it is very important 
landmark in order to distinguish the examined muscle from the adjacent ones.  
Structure and appearance of skeletal muscles changes with ageing. In addition to age- 
related muscle mass reduction, muscle quality changes include increased adipose 
tissue accumulation and water content within muscle that appear highly hyperechoic. 
Muscle disuse results in altered composition and increased intramuscular fat 
accumulation. This condition is accompanied by a severe loss of muscle strength.  
The examiner should pay attention to evaluate muscles with a correct angle of 
incidence of the US beam to avoid anisotropy artefacts. When the US beam is not 
perpendicular, the muscle shows a loss of echogenicity in structure (Fig. 8).  
Because muscle tears and hematomas may appear hypoechoic, it is important to 













Fig. 8. US scan of medial gastrocnemius muscle showing correct insonation (a) and 







































Sonoelastography (SEL) is a recently developed imaging technique which 
allows for qualitative visual or quantitative measurements of the mechanical 
properties of tissues. It is based on the principle for which, applying an extrinsic 
(mechanical or physical) stress, it is possible to induce changes in a determined 
tissue, depending on the elastic properties of the tissue itself; hence, qualitative 
and/or quantitative measurements of the elastic changes induced through the tissue 
could be obtained, usually by mean of an ultrasound transducer in clinical practice. 
The recent diffusion of SEL into commercially available ultrasound systems has 
promoted the development of many studies regarding the potential clinical 
applications of this technique in different clinical fields (Bamber 2013, Barr 2015, 
Sigrist 2017, Tang 2015) and, in particular, in the musculoskeletal system (Lehaoux 
2020, Brandenburg 2016, Sconfienza 2014, Eby 2013, Klauser 2014).  
 
2.1 Elasticity: basics principles  
The elasticity of a material represents its tendency to resume its original shape and 
size after being subjected to a deforming force or stress. Fluids resist a change in 
volume but not in shape: they have only ‘volume elasticity’. Solids instead resist 
changes in volume and shape: they present rigidity or ‘shear elasticity’, as well as 
volume elasticity. Viscoelastic fuids also exhibit elasticity in certain conditions 
(Askeland 2006.).  
It is essential that the terms stress and strain be defined because the elasticity of a 
material is described in terms of a stress-strain relation: the ‘strain’ is the relative 




For a homogeneous isotropic solid, the ratio of stress-strain is a constant, called the 
‘modulus of elasticity’. A modulus measures the amount of force per unit area 
(stress) needed to achieve a given amount of deformation and usually is expressed in 
units of Pa. A higher modulus typically indicates that the material is harder to deform 
(Meriam 2012).  
Three moduli are commonly used to define elasticity:  
• Young’s modulus (E) represents longitudinal elasticity and is defined by the ratio 
between the stress and the strain. Young modulus E = S/e.   
• Shear or torsion modulus (G) represents transverse elasticity.   
• Bulk or volume modulus (K) represents volume elasticity.   
A stress determines two types of mechanical waves in the tissue:   
1. Compression wave that compresses tissue little by little, inducing a displacement 
parallel to the propagation direction   
2. Shear wave that is responsible of a slip of different tissue layers, relative to each 
other, inducing a displacement perpendicular to the wave propagation direction   
The ultrasound elastography quantitative techniques do not directly measure the 
Young’s modulus but the speed V of shear wave propagation.   
The velocity V of the shear wave is related to shear modulus µ (shear):  
µ =rV2 with r = tissue density  
The shear modulus µ is itself connected to the elastic modulus:  
E = 3 µ 




the elastic modulus E according to the formula:  
E = 3rV 2 
For computations, the tissue density is assumed to be constant and equal to 1000 
kilograms per square mm.  
The shear modulus describes the response to shear forces, Young’s modulus 
describes the response to linear stress (tensile stress) and bulk modulus represents the 
response (in all directions) to uniform compression; it is usual for values of shear and 
Young’s modulus to be reported in the studies regarding the investigation of elastic 
properties of tissues by means of ultrasound (Lerner 1990).  
So the aim of elastography is to assess tissue stiffness based on three steps:  
1. Excitation: transmission of stress in a tissue  
2. Acquisition: recording the signal induced by the tissue deformation due to the 
stress (RF or B-mode data)  
3. Analysis: analysis of tissue strain induced by the propagation of the stress  
Human body has a mechanical behaviour similar to a soft homogeneous and isotropic 










2.2 Modalities  
There are several elastographic techniques which can be classified based on the 
temporal characteristics of the excitation, the excitation source, and the method used 
to detect tissue motion. 
 
2.2.1 Excitation Frequency  
Elasticity imaging techniques can generally be classified by the excitation frequency 
into two categories.  
1. Static Excitation: the excitation is applied slowly to allow tissue deformation to 
reach a steady-state. One of the earliest works to adopt this approach was Ophir et al.  
in 1991. In that study, tissue was imaged before and after step-wise compression 
using ultrasound, and images of strain, or ‘elastograms’, were obtained from tissue 
displacement. Areas of low strain correspond to hard regions, and high strain to soft 
regions. Thus, strain images are capable of displaying relative differences in stiffness. 
This approach has been used for applications such as tumor detection, 
characterization of vascular plaques, and imaging thermally ablated tissue. Today, 
static elastography is available on most commercial ultrasound systems. Typically, 
the operator applies compression on the tissue directly using the imaging transducer. 
The main drawback of static elastography is that it does not allow quantification of 
stiffness unless the distribution of applied stress within the tissue is known. Since this 
is usually not available in practice, it is a non-quantitative technique.  
2. Dynamic Excitation: the excitation applied is of short duration (transient) or 
harmonically oscillating at high frequency. The tissue response in this case is 
governed by the wave equation. Under simplifying assumptions, the speed of wave 
propagation in tissue can be directly related to its stiffness. This can be exploited by 




tissue. These methods have been investigated for quantifying the stiffness of various 
types of tissue, including liver, breast, cardiac, skeletal muscle, artery, kidney, 
cornea, and brain. Commercial implementations of elasticity imaging using dynamic 
excitation include FibroScan (Echosens, Paris, France), Virtual TouchTM tissue 
quantification (Siemens Healthcare, Ultrasound Business Unit, Mountain View, CA, 
USA), Aixplorer MultiWaveTM Ultrasound System (SuperSonic Imagine, Aix-en-
Provence, France) and MR-Touch (GE Healthcare, Buckinghamshire, UK). While 
dynamic excitation methods allow a quantitative measure of stiffness to be obtained, 
images formed using wave speed measurements in general have low spatial 
resolution, and can be susceptible to artifacts in heterogeneous media.  
 
2.2.2 Excitation Source  
Three types of mechanical excitation have been used in elasticity imaging.  
1. Mechanical actuators: these can be applied to the skin surface to deform the tissue 
underneath. They can be simple devices, such as plates or the imaging transducer for 
applying a static compression, or punches for exciting transient wave propagation. 
Vibration devices offering precise frequency control can be used for dynamic 
excitation. Interstitial devices, such as intravascular balloons for inducing strains in 
arteries, have also been used. In general, the amplitude of displacements generated by 
mechanical actuators applied external to the body in deep lying tissue can be limited 
by body habitus (obesity and ascites). In addition, wave propagation in tissue is often 
induced through mode-conversion at the boundary of structures, which can lead to 
complicated wave fields and makes the reconstruction of elastic parameters a 
challenging task.  
2. Acoustic radiation force: ARF generated by ultrasound can be used to provide 
mechanical excitation directly to the focal region of an acoustic beam. This allows 




avoid interference from intervening fat layers, ascites, or boundaries of surrounding 
structures. It is attractive for use in ultrasound-based elasticity imaging, as the same 
transducer can be used for both excitation and imaging. However, significant 
displacements can only be induced axially along the beamline direction and are small 
(on the order of microns from conventional diagnostic ultrasound transducers). ARF 
is predominantly used for dynamic excitation, but can also be used to apply steady-
state excitation for short durations (typically milliseconds) (Nightingale 2011).  
3. Physiological motion: these methods utilize motion due to respiration, arterial 
pressure, cardiac, or other muscle activity to provide excitation. These sources have 
been used to derive elasticity information in arteries, skeletal muscle, and 
myocardium. Physiological motion can produce appreciable deformation at remote 
regions inside the body. However, external control of this source of excitation is 
usually not possible.  
 
2.2.3 Detection Methods  
The main methods used for detecting tissue deformation in elasticity imaging are:  
1. Ultrasound The first non-invasive measurements of tissue stiffness were made 
using ultrasound. These early works took advantage of the real-time imaging 
capabilities of ultrasound and available Doppler processing techniques for detecting 
tissue motion. Today, it remains the most widely used imaging modality for elasticity 
imaging, due to short acquisition times (within seconds), portability, low cost, and its 
ability to also provide mechanical excitation with ARF. However, conventional 
ultrasound is only able to provide 2D cross-sectional images of the anatomy, and has 
limited sensitivity to displacements perpendicular to the beam direction, which 
restricts its ability to fully characterize tissue deformation.  




magnetic resonance elastography (MRE). It was first proposed by Muthupillai et al. 
in 1995. This method of detection can be used to image deformation from quasi-static 
compression, or combined with external vibrators to image wave propagation. 
Recently, ARF induced tissue deformation has also been imaged using MR. MR has 
the advantage of being a 3D imaging modality and has the capability to measure 
displacement fields with equal sensitivity in any direction. However, the long 
acquisition time required (on the order of minutes) means that most MRE studies are 
limited to data from a single 2D plane of the anatomy. 
 
2.2.4  Sonoelastography in clinical practice  
In clinical practice, among different imaging methods, elastography has emerged in 
the 90s to provide an estimation of tissue elasticity (Ophir 1991, Lerner 1990). Static 
and quasi-static elastography were first used to estimate the strain of the muscle 
qualitatively. Since they offer little advantage, another generation called dynamic 
elastography, based on propagation of shear waves, emerged (Altahhan 2016). It uses 
an acoustic radiation force to create and propagate a shear wave offering a 
quantifiable spatial representation of viscoelastic characteristics of soft tissue (Shiina 
2015).  
Resuming, two main types of sonoelastography have become established in clinical 
practice: 
• Strain elastography: it is also described as ‘quasi-static elastography’, ‘compression 
elastography’ and ‘real-time elastography’. The stress is applied by repeated manual 
compression of the transducer, and the amount of tissue deformation (strain) relative 
to the surrounding normal tissue is measured, usually with a tracking algorithm 
working on the radio frequency data. The resulting data can then be used to form an 
image that is coded in colour or greyscale to show the pattern of strain, which is 




qualitative data; however, regions of interest (ROIs) can be positioned over target 




Fig. 9. Strain elastography. (a) Qualitative analysis: the modulus of elasticity of the 
soft tissue scanned in the B-mode image is represented by a superimposed colour- 
coded map in which (in this case) the lower values are depicted in red and the higher 
ones in blue; (b) it shows the possibility to perform also a semi-quantitative analysis 
of the strain elastogram with placement of two ROIs in order to take definite 
measurements of the Young’s modulus of elasticity of the targeted tissue. The green-
coloured spring-shaped gure shown in the left bottom of both the elastograms 
indicates that the pressure the operator performed with the transducer was appropriate 
to produce an adequate stress to get the elastogram.  
 
 
• Shear wave elastography: it is a very potential technique for the noninvasive 
quantification of tissue stiffness. Shear waves in the body can be induced by various 
methods, including physiological motion, external mechanical excitation or acoustic 
radiation force (by a focused ultrasound beam). Shear waves are transverse, they are 
rapidly attenuated by tissue, they travel much more slowly (between 1 and 10 m/s) 
and they are not supported by liquids of low viscosity. Using a real-time imaging 
modality such as ultrasound (but also magnetic resonance), the underlying tissue 
stiffness can be estimated measuring the produced shear wave speeds. Their speed is 




tissue, and there is a simplified formula for converting between the shear wave speed 
and the elastic modulus of the tissue to locally quantify its stiffness in kiloPascals 
(kPa). In contrast to strain elastography, this technique allows for the performance of 
quantitative analysis of the tissue stiffness (Fig.10). 
 
 
Fig. 10. Shear wave elastography. The focused US beam pushed by the US probe  
generates shear waves into the target tissue (left); their velocities are detected by the 
same transducer and represented on the B-mode image (right) by a superimposed 
colour-coded map in which (in this case) the lower values are depicted in blue and 
the higher ones in red, giving a quantitative analysis of tissutal stiffness (higher 




There are some variations of this method in clinical practice, depending on the 




– Transient elastography (TE): it is a system developed and commonly used for liver 
fibrosis assessment, in which a mechanical piston within an ultrasound transducer is 
used to apply a push to the skin over an intercostal space. The speed of the produced 
shear waves into the liver, along the direction of the ultrasound beam, is measured in 
a way similar to M-mode (Tang 2015).  
– Acoustic radiation force imaging (ARFI): in this technique, a focused ultrasound 
‘pushing’ beam (with intensity below the threshold for bio-effects) is used to induce 
tiny displacements in soft tissue along its direction and generate orthogonal shear 
waves that propagate sideways in tissue. The shear wave speed or amplitude is 
detected by conventional ultrasound using tracking algorithms and is used to quantify 
the underlying tissue stiffness.  
Shear wave speed measurement could be made by a single small measurement box 
positioned by the operator within the tissue adjacent to the pushing beam and/or 
could be extended to sequential multiple pushing and measurement points in order to 
construct a colour-coded map of the shear wave speed, which is also quantitative with 
positionable ROIs. ARFI images represent the spatial distribution of tissue stiffness 
(Hoyt 2008).  
– Supersonic shear imaging (SSI): it is a similar system which uses multiple acoustic 
radiation force impulses focused at different depths to create an extended cylindrical 
wavefront (Bercoff 2004). These excitations are applied supersonically so that the 
shear waves generated from different depths constructively interfere adding each 
other’s and dedicated ultrasound transducers could detect and measure them 
(Gennisson 2010).  







Fig. 11. Shear wave elastography of rectus femoris muscle: after the generation of the 
‘pushing’ beam by the transducer, the values of the shear modulus in the targeted 
area are represented by mean of a colour-coded map set as represented by the 
coloured bar on the left of the screen. It is possible to get also a quantitative analysis 
of the investigated tissue by placing some ROIs (with modifiable dimensions) over 
the map and get the corresponding value at the left bottom angle of the screen. Note 
that, on the right elastographic map, the stiffer areas in the centre of the map 
correspond to the central rectus femoris aponeurosis.  
 
 
Table II. The technical characteristics of the different elastographic methods.  
  Quasi-static                  Dynamic  





Mechanical  (external 
compression) or physiological  
Ultrasonic 
(radiation force)  
Mechanical (pulse by 





Surface or internal structure  Different depths  Surface  Different depths  
Involved 
modulus  
Young  Shear  Shear  Shear  
Measured 
parameters  
Displacement → strain  
Shear wave 
velocity  
Shear wave velocity  Shear wave velocity  
Visualization  Temporal strain map  One image  







































3. Pathophysiology of spasticity  
 
Spasticity is a stretch reflex disorder, manifested clinically as an increase in 
muscle tone that becomes more apparent with more rapid stretching movement. It is a 
common consequence of lesions that damage upper motor neurons causing upper 
motor neuron syndrome (UMNS).  
 
3.1. Definition and Clinical Features  
The core feature of spasticity is the exaggeration of stretch reflexes. The result is the 
velocity-dependent increase in resistance of a passively stretched muscle or muscle 
group. In 1980, Lance published this frequently cited definition: “Spasticity is a 
motor disorder characterised by a velocity-dependent increase in tonic stretch 
reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyperexcitability 
of the stretch reflex, as one component of the upper motoneuron syndrome” (Lance 
1980). This definition emphasizes the fact that spasticity is just one component of 
UMNS.  
Besides the dependence from velocity, spasticity is also a length-dependent 
phenomenon. In the quadriceps, spasticity is greater when the muscle is short than 
when it is long. This is probably one of the mechanisms underlying the so-called 
clasp knife phenomenon. On the contrary, in the flexor muscles of the upper limb and 
in the ankle extensors (triceps surae), spasticity is greater when the muscle is long.  
Spasticity is more often found in the flexor muscles of the upper limb (fingers, wrist, 
and elbow flexors) and in the extensor muscles of the lower limb (knee and ankle 





3.2 Stretch Reflex and Muscle Tone in Healthy Subjects  
In healthy subjects, stretch reflexes are mediated by excitatory connections between 
Ia afferent fibers from muscle spindles and alpha-motoneurons innervating the same 
muscles from which they arise. Passive stretch of the muscle excites the muscle 
spindles, leading Ia fibers to discharge and send inputs to the alpha-motoneurons 
through mainly monosynaptic, but also oligosynaptic pathways. The alpha-
motoneurons in turn send an efferent impulse to the muscle, causing it to contract. 
Surface EMG recordings in a normal subject at rest clearly show that passive muscle 
stretches, performed at the velocities used in the clinical practice to assess muscle 
tone, do not produce any reflex contraction of the stretched muscle. For instance, 
recording the EMG of elbow flexors during imposed elbow extension, no stretch 
reflex appears in the biceps when the passive displacement occurs at the velocities 
usually used during the clinical examination of muscle tone (60 –180 per second). It 
is only above 200 per second that a stretch reflex can be usually seen. Therefore, 
stretch reflex is not the cause of the muscle tone in healthy subjects. The muscle tone 
in healthy subjects is completely due to biomechanical factors (Thillmann 1991).  
 
3.3 Muscle Tone in Patients with Spasticity: The Exaggerated Stretch Reflex  
Differently from healthy subjects, in patients with spasticity evaluated at rest 
(completely relaxed), a positive linear correlation between EMG activity of the 
stretched muscle and stretch velocity was found using a range of displacement 
velocities similar to that used in the clinical practice to evaluate the muscle tone. 
When the passive stretch is slow, the stretch reflex tends to be small (low amplitude) 
and the tone may be perceived relatively normal or just increased. When the muscle 
is stretched faster, stretch reflex increases and the examiner detects an increase in 





Although spasticity is velocity-dependent, surface EMG recordings show that in 
many cases if the stretch is maintained (velocity = 0), the muscle still keeps 
contracting, at least for a time. So, although spasticity is considered classically 
dynamic, there is also an isometric tonic muscle contraction after the stretch reflex 
elicited in a dynamic condition (Trompetto 2014). 
 
3.4 Soft Tissue Changes: Intrinsic Hypertonia  
Spasticity is responsible for the velocity-dependence of muscle hypertonia in patients 
with UMNS. However, it must be stressed that in such patients muscle hypertonia is a 
complex phenomenon, where spasticity represents only one aspect. Hypertonia in 
patients with UMNS, therefore, can be divided into two components: hypertonia 
mediated by the stretch reflex, which corresponds to spasticity, and hypertonia due to 
muscle contracture, which is often referred as non-reflex hypertonia or intrinsic 
hypertonia. In contrast to spasticity, in intrinsic hypertonia resistance to passive 
displacements is not related to the velocity of the movement (Marinelli 2017).  
 
3.5 The Exaggeration of Stretch Reflex  
Theoretically, the exaggeration of the stretch reflex in patients with spasticity could 
be produced by two factors. The first is an increased excitability of muscle spindles, 
for which passive muscle stretch induces a greater activation of spindle afferents with 
respect to that induced in a normal subject. The second factor is an abnormal 
processing of sensory inputs from muscle spindles in the spinal cord, leading to an 
excessive reflex activation of alpha-motoneurons. The velocity-dependence of 
spasticity can be attributed to the velocity sensitivity of the Ia afferents. However, it 
has been suggested that II afferent fibers, which are length-dependent, could be 




dynamic phase of the stretch reflex in patients with spasticity (Sheean 2002).  
 
3.6 Upper Motor Neuron Syndrome: a Complex Picture  
After a stroke or a trauma damaging upper motor neurons, weakness and loss of 
dexterity are immediately apparent. Other signs can be hypotonia and loss (or 
reduction) of deep tendon reflexes. These signs are known as the negative features of 
the UMNS. Sometime later, other signs appear, characterised by muscle overactivity: 
spasticity, increased deep tendon reflexes (also called tendon jerks), clonus, spasms, 
Babinski sign, positive support reaction, cocontraction, spastic dystonia, and 
associated reactions. These signs are known as the positive signs of the UMNS 
(Trompetto 2014). 
The hyperexcitability of the stretch reflex produces spasticity, clonus, and the 
increase of deep tendon reflexes. Increased excitability of the physiological exor 
withdrawal reflex produces flexor spasms of the lower limbs, commonly seen after 
spinal cord injuries. On the contrary, cocontraction and associated reactions do not 
depend on spinal reflexes; therefore, they are efferent phenomena. Also spastic 
dystonia is thought to depend upon an efferent drive (Marinelli 2017).  Cocontraction 
is the simultaneous contraction of both the agonist and the antagonist muscles around 
a joint. In healthy subjects, the voluntary output from the motor cortex activates the 
motoneurons targeting the agonist muscles and, through the Ia interneurons, inhibits 
those innervating the antagonist muscles (reciprocal inhibition). In the UMNS, 
cocontraction is due to the loss of reciprocal inhibition during voluntary command. 
This is likely to be the most disabling form of muscle overactivity in patients with 
UMNS, as it hampers generation of force or movement.  Associated reactions are 
involuntary movements due to the activation of paretic muscles which occur during 
voluntary activation of unaffected muscles or during involuntary events such as 




Spastic dystonia refers to the tonic contraction of a muscle or a muscle group when 
the subject is at rest. It can be described as a relative inability to relax muscles. 
Spastic dystonia can alter resting posture contributing to the hemiplegic posture: the 
upper limb is flexed and adducted; the lower limb is extended (Sheean 2009). 
Although not induced by muscle stretch, spastic dystonia is sensitive to muscle 
stretch and length. It can be triggered by muscle stretch, even though prolonged 
stretch can reduce it. The common view is that spastic dystonia is an efferent 
phenomenon, mediated by an abnormal pattern of supraspinal descending drive. The 
inability to relax the muscle (i.e., spastic dystonia) is a central feature in spastic 
patients and is likely to be connected to the prolonged firing of alpha-motoneurons, a 
well-documented phenomenon in patients with UMNS, possibly having a role in the 
isometric tonic muscle contraction often seen in spastic patients after the dynamic 
phase of stretch reflex. 
 
3.8  Supraspinal Influences on the Stretch Reflex  
Spasticity is not related to the pyramidal system. It is due to loss or reduction of the 
inhibitory influences conducted by the dorsal reticulospinal tract and is maintained 
through the facilitatory influences conducted by the medial reticulospinal tract. Brain 
lesions cause spasticity when they disrupt the facilitatory corticobulbar fibers, thus 
leading to the inhibition of the ventromedial reticular formation, from which the 
dorsal reticulospinal tract takes its origin. Incomplete spinal cord lesions cause 
spasticity when they destroy the dorsal reticulospinal tract sparing the medial 
reticulospinal tract. In the complete spinal cord lesion, both the facilitatory and 
inhibitory influences on the stretch reflex are lost. As all these tracts inhibit the 






























4. Research context 
 
 
B-mode conventional ultrasonography (US) is widely utilized for 
musculoskeletal pathology as a first-line approach mainly because of real-time access 
and the relatively low costs (Klauser, 2014). Sonoelastography is a method that can 
assess the mechanical properties of soft tissues by US imaging, in particular, a further 
development of such technique - shear wave elastography (SWE) - provides 
quantitative evaluation of elastic properties by measuring the propagation velocity 
distribution of the directional shear waves, produced by an ultrasound pulse (Bamber 
2013). 
In the past decade, sonoelastography has been established in clinical practice as an 
effective diagnostic method for the quantitative assessment of liver fibrosis, for breast 
and thyroid cancer; more recently it has been introduced as a promising diagnostic 
tool in musculoskeletal pathology to assess muscle and tendon elastic properties 
related to degeneration, injury and healing (Ryu, 2017, Sconfienza 2014, Creze 
2018). 
Recently some authors demonstrated good to excellent interobserver reproducibility 
and intraobserver repeatability in radiologists, validating the feasibility and reliability 
of ultrasound SWE to assess mechanical properties (stiffness) of skeletal muscle 
tissue in the upper and lower extremities  (Phan 2019, Sarabon 2019, Creze 2018).  
Following stroke, paretic limbs may develop muscle hypertonia with a prevalence 
established in a number of clinical studies ranging from 30% to 80% (Lehoux 2020, 
Feigin 2017), often related to the appearance of spasticity or spastic dystonia, both 
related to alpha motor neuron hyperexcitability. Strictly speaking, while spasticity 
refers to a velocity-dependent muscle hypertonus due to stretch reflex 
hyperexcitability, spastic dystonia not only causes hypertonus during passive muscle 




stretching (Marinelli, 2017). Apart from these neural-mediated reflex phenomena, it 
is well recognized that paretic muscles undergo intrinsic structural changes such as 
muscle shortening (reduction in number of sarcomeres and fibers size with different 
distribution) and increased fibrosis (increase in extracellular matrix and collagen 
concentration with inferior mechanical properties) related to reduced use and 
immobilization (Trompetto, 2014, Lehoux 2020, Sions 2012, Lee 2019).  
Botulinum toxin A (BoNT-A) is considered the first-choice treatment for spasticity 
affecting a limited number of muscles. It reduces muscle activity by inhibiting 
acetylcholine release at neuromuscular junction level and is therefore able to reduce 
neural-mediated muscle hypertonia. 
The goals of botulinum toxin treatment include improving limb function, increasing 
passive/active range of motion (ROM), facilitating better hand hygiene, reducing pain 





The BoNT-A treatment requires a reliable measure of spasticity to determine the 
efficacy of the intervention over time. To date, this remains challenging because of 
the lack of a gold standard (Starky 2005). Although clinical parameters (i.e.: 
Modified Ashworth Scale - MAS) have been used as clinical assessments before and 
after treatment, they are subjective and non-quantitative (Sommerfeld 2012). Both 
conventional surface electromyography (EMG) and intramuscular EMG have been 
proposed for a quantitative evaluation but they measure only electrical activity of 
muscles. 
In such setting, SWE could gain an important role due to its potential capability to 
quantitatively assess the contribution of viscoelastic properties to soft tissue stiffness.  
Tough, the possibility to match the electromyographic evaluation of spasticity and 




evaluation, should tell apart neural-mediated and intrinsic muscle stiffness.  
Of course, patients with spasticity following stroke are ideal patients for such 




4.2 Study objectives 
 
• Validate elastosonography to assess spastic muscle stiffness: if this method is 
able to detect stiffness changes before and after botulinum toxin treatment, 
then it is likely suitable to complement electromyography in the assessment of 
muscle hypertonia 
• Compare the amount of reduction of quantitative measure of muscle hypertonia 
using SWE and electromyography in order to distinguish the contribution of 
reflex hypertonia and intrinsic muscle changes by comparing the spastic 
muscle before and after botulinum toxin treatment (endpoint 1) and with the 





From September 2018 to December 2019 we prospectively recruited 16 patients (5F; 
age:59,6±15,2 years, m±SD; range:46-79) affected by spasticity in at least one 
muscle group of only one side of the body following stroke by at least 3 months. If 
the patient had already been treated with botulinum toxin, the time interval between 
the last injection was at least of 4 months.  
Inclusion criteria are: 
• Age of 18 or more 




• Spasticity affecting at least one muscle segment with unaffected contralateral 
homologue 
• Ability to sign the informed consent 
Exclusion criteria are: 
• Concomitant parkinsonism 
• History of lesions affecting the muscle to be evaluated 
 
The institutional review board at I.R.C.C.S. Ospedale Policlinico San Martino 
approved the study and all patients provided written informed consent before data 




















5. Materials and Methods 
 
 
All recruited patients underwent a neurological examination and assessment of 
muscle hypertonia using the modified Ashworth scale (MAS).  
The MAS score was obtained on all patients by an experienced physician (L.M., 
neurologist) The MAS is based on one quick stretch and is scored on the following 
scale (Pandyan 2003, Bohannon 1987):  
0 = no increase in muscle tone (i.e., normal)  
1 = slight increase in muscle tone, manifested by a catch and release or by minimal 
resistance at the end of the ROM when the affected part(s) is moved in flexion or 
extension  
1+ = slight increase in muscle tone, manifested by a catch, followed by minimal 
resistance throughout the remainder (less than half) of the ROM  
2 = more marked increase in muscle tone through most of the ROM, but affected 
part(s) easily moved  
3 = considerable increase in muscle tone, passive movement difficult  
4 = affected part(s) rigid in flexion or extension. 
 
 
Among the muscles going to be treated with botulinum toxin following clinical 
examination, a muscle with MAS > 0 was selected to measure spastic dystonia and 
spasticity. Muscles characterized by large bulk and reduced distance from the 
ultrasound transducer (such as biceps brachii muscle) were preferred. 
All patients underwent clinical assessment, surface electromyography (sEMG), SWE 
and B-mode conventional ultrasound assessments. SWE was also performed on the 




The examiners evaluated patients independently and blinded to each other. 
MAS, SWE, sEMG and MHS assessments were performed just before botulinum 
toxin injection (T0) and one month after (T1) with same protocols: such time interval 





Self-adhesive electrodes (Neuroline 700, Ambu A/S, Ballerup, Denmark) were 
placed at 1cm apart over muscle belly for bipolar recording following SENIAM 
(Surface Electromyography for Non-Invasive Assessment of Muscles) guidelines 
(Hermens 1999). Signals were acquired by a BIOAMP LT unit (Vertigo, Genova, 
Italy) and underwent a 20-500 Hz band-pass filter for offline processing using a 
custom software running in Labview (National Instrument, Austin TX, USA). 
Subjects were lying supine on the examination table in a quiet room while attempting 
to remain relaxed. 
1) Spastic dystonia was assessed by recording sEMG while the muscle remained in a 
neutral position, before performing passive limb movements. Each subject entered 
analysis with the average rectified value (ARV) during a 30s recording. 
2) Spasticity was assessed in the selected muscle by recording sEMG during 10 
passive stretches performed at a reproducible speed, according to a previously 
validated methodology (Marinelli 2013). The selected muscle was stretched with 
linear (ramp and hold) passive movements following the pacing provided by an 
emulated metronome. The beats per minute pace (BPM) was decided for each patient 
according to the muscle and the amount of spasticity and maintained the same at both 
time points. Each subject entered analysis with the mean ARV obtained from 10 








A LOGIQ E9 ultrasound system equipped with a 9L linear array transducer with 
Shear Wave Elastography technology (GE Healthcare, General Electric Company, 
Chicago, Illinois, US) was used to acquire B-mode images, and shear wave 
elastographic measurements. Such technology uses ‘comb-push’ excitation source 
(multiple pushing beams transmitted on the transducer simultaneously in a comb-like 
pattern), time-interleaved shear wave tracking (data interpolation), directional filters 
and a time-of-flight algorithm which is used to estimate the local Shear Wave speed 
at every location in the region of interest.  
SWE measurements were performed by a radiologist (A.C.) with 10-year-experience 
in musculoskeletal ultrasound and 5-year-experience in US-elastography at two time 
points: prior to BoNT-A intramuscular administration (T0) and 4 weeks after 
injections (range: 22-32 days). Patients have been placed in the supine position; the 
patients’ arm was held in a non-stretched position with target muscle in a shortened 
position. Transmission gel was applied, the ultrasound probe was placed on the skin 
and underlying transverse sections of the muscle belly were scanned. Standard 
machine settings for acquiring ultrasound data included a maximum image depth of 
10 cm, scanning frequency of 7 MHz, single image focus, tissue harmonic imaging 
and turned off speckle reduction function.  
We switched to elastographic mode to measure muscle stiffness, setting shear wave 
velocity (SWV, m/s) as unit of measurement (Eby 2016). Special attention was paid 
to placing the transducer lightly on the skin, applying as little pressure as possible on 
the skin and underlying muscles (in order to prevent any minimal additional pressure 
on the muscle which could lead to overestimated measures). The region of interest 
(ROI) for estimating stiffness of the muscle was set between depths of 1.0 and 5.0 cm 
from the skin and displayed as color-coded SW-velocities (SWV) map on the 
ultrasound screen. SWVs in the ROI were calculated after a shear wave quality map 




(meaning appropriate push beam and speeds detection). Quantitative SWV values 
were measured using a rectangular dimension-variable ROI (maximum dimensions: 2 
x 2 cm). A total of 10 SWV measurements for each muscle belly were obtained 
avoiding aponeurosis and thickest intramuscular septa, covering the widest area of 
muscular fibers (Fig. 12); then, for each muscle, a median velocity (m/s) ± 
interquartile range (IQR) was provided in order to get a comprehensive estimate of 
the muscular stiffness. We also performed the same evaluation on the same muscle in 
a maximum-achievable stretched condition with muscle fibers elongation, while a 
second operator was keeping the arm of the patient passively extended, as done for 
EMG measurements.  
 
 
Fig. 12. Scheme illustrating SWE acquisition on short axis of muscular fibers: the 
transducer is placed on muscular belly performing consecutive transverse scans with 
the aim of assess the maximum amount of muscle (left); in each scan SW velocities 
are measured in the positioned ROI generating the relative color-coded elastogram 




Further, analogous SWE measurements were repeated rotating the probe on 
longitudinal planes of the muscle (as shown in Fig. 13). 
 
 
Fig. 13. Scheme illustrating SWE acquisition on long axis of muscular fibers: the 
transducer is placed on muscular belly performing consecutive longitudinal scans 
with the aim of assess the maximum amount of muscle (left); in each scan SW 
velocities are measured in the positioned ROI generating the relative color-coded 




The same protocol was then performed on the contralateral homologue muscle in 
order to get differences between paretic and non-paretic side. 
 
Meantime, since the SWE evaluation is provided on the basis of a conventional B-




the selected muscle was assessed by the same operator as follows:  
 
1. normal background echogenicity with clearly internal septa;  
2. increase in background echogenicity while intramuscular septa are still definable; 
3. increase in background echogenicity and less definable septa;  




Fig. 14. Modified Heckmatt scale representation. Normal background echogenicity 
with clearly internal septa (I); increase in background echogenicity while 
intramuscular septa are still definable (II); 3. increase in background echogenicity 
and less definable septa (III); increase in background echogenicity without definable 
septa (IV).  
 
 
5.3 Botulinum toxin A injection  
 
Botulinum toxin A specifically inhibits acetylcholine release at the neuromuscular 
junction, thus reducing muscle contraction. Intramuscular injection of BoNT-A is 
commonly used for the treatment of localized spasticity (Brin 1997). 
One hundred-unit vials of incobotulinumtoxinA (Merz Pharma, Frankfurt am Main, 
Germany) were diluted with 2 ml of preservative-free normal saline. Muscles were 
injected according to current guidelines according to muscle size and amount of 
spasticity. Generally, each muscle was injected with 20-100 IU and each patient 




experience in post-stroke spasticity treatment, performed BoNT-A injections under 
US-guidance. 
 
5.4 Statistical analysis 
 
Data are expressed as mean±SD. For non-Gaussian distributions data are also 
reported as medians and interquartile range (IQR, 25%-75%). Statistical analyses 
were performed using GraphPad Prism v5.0 software (GraphPad Software Inc., La 
Jolla, CA, USA). Normal distribution of data was assessed by Shapiro Wilk test. 
Depending on data distribution, paired ANOVA tests for Gaussian and non Gaussian 
distributed data were performed to evaluate differences among the groups of 
measurements, using Dunn’s or Bonferroni’s post-tests for one-way and two-way 
analyses, respectively. For comparison between two groups of measurements, paired 
Student’s t test or Wilcoxon matched paired test were applied for normal and non-
normal distributed data, respectively. Spearman’s r was calculated to assess 
correlation between Heckmatt scale and T0 or T1 measurements; p values <0.05 were 
considered statistically significant. Effect sizes were calculated as Cohen’s d using 
effsize library for R (v3.6.1). 

















































One of our participant exited the study because of further intervened health 
problems and another patient was excluded from the study because a concomitant 
parkinsonism was diagnosed, matching one of our exclusion criteria.   
Finally, 14 patients (5F; age: 58,4±14,1 years, m±SD; range:46-78) were included in 
the study with a total of  28 muscles evaluated. Detailed data are exposed in Tab III. 
 
 
Tab. III. Anamnestic features and muscle evaluated of patients included in the study.  
 
 
6.1 Surface Electromyography 
In one subject (#14) a MAS=4 prevented the assessment of spasticity since the elbow 
joint could not be passively displaced. Average Rectified Value of the EMG signal 
(ARV) (Hermens, 1999) detected in muscles in neutral position resulted 8.07±8.24 
µV (mean±SD) at T0 and 2.65±1.62 µV (mean±SD) at T1; ARV detected during 
passive extension of muscles resulted 18.13±22.61 µV (mean±SD) at T0 and 
7.30±3.70 µV (mean±SD) at T1. Both spastic dystonia and spasticity significantly 







Fig.15  Chart illustrating the electromyographic activity (µV) measured in spastic 
muscles before (T0) and 4 weeks after (T1) botulinum toxin A injection at muscle 





6.2 Modified Ashworth Scale 
MAS values at T0 were 2.32±0.87 (mean±SD); at T1 significantly decreased to 
1.79±1.03, mean±SD (p<0.01). (Fig. 16). No significant correlation was found among 
MAS values reduction at T1 (ΔT0-T1) and Δ values of SWE and EMG between the 






Fig. 16 Chart illustrating the significant difference in MAS scores assessments of 






6.3 Shear Wave Elastography 
A total of 224 SWE values resulted considering both time points, subdivided into 8 
different groups in relation to the 4 different variables: time point (T0 vs T1), body 
side (paretic limb vs non-paretic limb), transducer orientation (tranverse vs 
longitudinal) and muscle condition (stretched vs non-stretched). 
Measurements obtained with transverse positioning of the probe, on non-paretic and 
non-stretched muscle (Group A) resulted 1.98±0.37(mean±SD) at T0 and 
1.97±0.38(mean±SD) at T1; 
Measurements obtained with longitudinal positioning of the probe, on non-paretic 
and non-stretched muscle (Group B) resulted 2.88±0.29(mean±SD) at T0 and 
2.86±0.29(mean±SD) at T1; 
Measurements obtained with transverse positioning of the probe, on non-paretic and 
stretched muscle (Group C) resulted 2.94±0.26(mean±SD) at T0 and 




Measurements obtained with longitudinal positioning of the probe, on non-paretic 
and stretched muscle (Group D) resulted 3.47±0.3(mean±SD) at T0 and 
3.50±0.34(mean±SD) at T1; 
Measurements obtained with transverse positioning of the probe, on paretic and non-
stretched muscle (Group Ap) resulted 2.39±0.55(mean±SD) at T0 and 
2.34±0.58(mean±SD) at T1; 
Measurements obtained with longitudinal positioning of the probe, on paretic and 
non-stretched muscle (Group Bp) resulted 3.18±0.34(mean±SD) at T0 and 
3±0.32(mean±SD) at T1; 
Measurements obtained with transverse positioning of the probe, on paretic and 
stretched muscle (Group Cp) resulted 3.30±0.27(mean±SD) at T0 and 
3.29±0.26(mean±SD) at T1; 
Measurements obtained with longitudinal positioning of the probe, on paretic and 
stretched muscle (Group Dp) resulted 3.87±0.44(mean±SD) at T0 and 
3.75±0.38(mean±SD) at T1. (Tab.IV) 
 
 
Overall, SWE measurements on paretic muscles assessed with a longitudinal 
positioning of the probe showed statistically significant reduction at T1 versus T0 
both in non stretched conditions (p=0.001) and in stretched conditions (p=0.0029) 







Fig. 17 SWE reduction between T0 and T1. In the upper-right quadrant is illustrated 
an example of an elastogram (superimposed to the B-mode image) generated by a 
ROI placed in biceps brachii muscular belly along the direction of the fibers at T0; in 
the lower right image the same evaluation at T1 shows lower values (lower left 
corners of the images). Images on the upper- and lower-left quadrant are the 
respective B-mode conventional US image automatically paired on the screen by the 
SEL software. 
 
Conversely, SWE assessments with a transverse orientation of the probe did not show 
a statistically significant reduction between the two time points in stretched 
conditions (p=0.66), and a slighly significant difference in non stretched ones (p= 
0.03).  
 
Sonoelastographic measurements on non-paretic muscles did not significantly 





All SWE measurements on paretic muscles are sistematically higher than 
correspective ones on non-paretic muscles (p<0.01 for all variables). 
Further, SWE measurements obtained in stretched conditions are sistematically 
higher than measures assessed in non stretched conditions. 
SWE measurements obtained with a longitudinal positioning of the transducer are 
sistematically higher than measures performed with a transverse orientation of the 
probe (p<0.01 for all variables) (Fig. 18). 
 
 
Fig. 18 Example of SWE difference between transverse and longitudinal 
assessments. In the upper-right quadrant is illustrated an example of an elastogram 
(superimposed to the B-mode image) generated by a ROI placed in a non-paretic, 
non-stretched biceps brachii muscular belly across the direction of the fibers; in the 
lower right image the elastogram generated along the direction of muscular fibers of 
the same muscle shows higher values expressed both qualitatively with different-
coloured map  and quantitatively in m/s (lower left corners of the images). Images on 
the upper- and lower-left quadrant are the respective B-mode conventional US image 
automatically paired on the screen by the SEL software (transverse US scan in the 







Tab. IV  SWE and MHS detailed data at T0 and T1 reported as mean±SD. SWE 
results are classified in columns in relation to the different variables in consideration. 
(NpnsAx: group A; NpnsLo: group B; NpsAx: group C; NpsLo: group D; PnsAx: 




Fig. 19 Chart illustrating SWE velocities (expressed as medians and IQR) assessed in 
paretic muscles at T0 and T1; significant difference (p<0.01) found in longitudinal 







Fig. 20 Chart illustrating SWE velocities (expressed as medians and IQR) assessed in 
non-paretic muscles at T0 and T1; only a slight significant difference (p:0.04) found 
in group B. 
 
 
6.4 Modified Heckmatt Scale 
MHS scores (2.29±0.73, mean±SD) did not change between T0 and T1. There was a 
positive correlation between MHS scores and SWE values: such correlation ranged 
from moderate to strong (Spearman r: 0.46 - 0.84; results in details in Tab. V) and is 
significant for every group apart from group D.  
 
 
Tab. V Correlation between MHS values and different SWE group of measurements: 






Fig. 21 MHS grade II. Conventional US appearance of biceps brachii and brachial 
muscles on non-paretic (NP) and paretic side (P) following stroke, as assessed with 
transverse US scans: on the left image normal US appearance of muscle with regular 
echogenicity of fibers and normal muscular fibers - intrasmuscular septa 
differentiation; the right image shows volume reduction of muscle and increase in 








Fig. 22. MHS grade III. Conventional US appearance of biceps brachii and brachial 
muscles on non-paretic (NP) and paretic side (P) following stroke, as assessed with 
longitudinal US scans: on the left image normal US appearance of muscle with 
regular echogenicity of fibers and normal muscular fibers - intrasmuscular septa 
differentiation; the right image shows volume reduction of muscle and significant 






6.5 Effect size 
The effectiveness of botulinum injection on SWE and sEMG measurements, 
expressed as effect sizes, is reported in tab VI. 
Cohen’s d estimate a larger effect on EMG values than longitudinal SWE ones (either 




Tab VI Effect sizes of longitudinal SWE and sEMG related to BoNT-A injection. 
 
 
6.6 Time since stroke 
Poor correlation was found among time since stroke and elastographic, 
electromyographic and MAS values.  
Conversely, good correlation emerged between time since stroke and MHS values 




































Surface electromyography is considered the gold standard for measuring 
spasticity and spastic dystonia, being the only technique able to record involuntary 
muscle activity during passive muscle elongations and at rest (Trompetto 2014). 
In recent years, many studies (Eby 2016, Gao 2018, Jakuboski 2017, Lee 2019, Le 
Sant 2018, Mathevon 2018, Wu 2017) used SWE with different approaches and 
protocols, in order to quantify muscular stiffness related to spasticity. 
To my knowledge, this is the first attempt to quantitatively assess the structural and 
neural-mediated components of spasticity by mean of sEMG and SWE. 
Two main observation resulted by this study. 
 
First, SWE, sEMG and MAS were able to detect the effect of BoNT-A on paretic 
muscles in terms of a significant decrease in their values, as previously demonstrated 
in several studies (Lehoux 2020). 
Following BoNT-A injection, both elastographic and electromyographic 
measurements decreased because both are affected by neural-mediated stiffness. Such 
results were expected and should be related to the fact that SWE estimates muscular 
stiffness measuring its viscoelastic behaviour, hence, is unable to properly 
differentiate stiffness due to muscle fibrosis or by muscle contraction (two 
simultaneous phenomena which sum up in spasticity).  
Cohen’s d values estimated a larger effect size on EMG measurements in respect to 
longitudinal SWE ones: indirectly, it may be speculated a steeper reduction of 
electromyographic activity compared to SWE-detected stiffness, which would reflect 
a reduction in neural-mediated stiffness but not that due to intrinsic muscle changes.  
Regarding SWE measurements, significantly (p<0.01) decreased values at T1 were 
limited to the group of measurements obtained with a longitudinal orientation of the 
probe in respect to the direction of muscular fibers.  




muscle and, moreover, are comparable with results from recently published studies 
(Creze 2018, Gennisson 2010, Lehoux 2020). Because of the well known physical 
assumption that skeletal muscle is an anisotropic (orthotropic), non-linearly 
viscoelastic and deformable tissue, shear waves generated into such tissue propagates 
in different ways in respect to the orientation of muscular fibers. It may be argued 
that shear waves which propagate on a transverse axis in respect to the direction of 
the muscular fibres, encounter a greater number of tissutal interfaces, resulting in 
more etherogeneous measurements. Conversely, shear waves which propagates along 
the direction of the muscular fibers could generate more homogeneous 
measurements.  
Further, orthotropic physical properties of skeletal muscle are also responsible for the 
fact that shear waves travel faster along the direction of the fibers than they do when 
perpendicular to them, which is another point resulted in the present study and 
already demonstrated by previous papers (Creze 2018, Dorado 2016, Eby 2016, 
Miyamoto 2015). 
Surface EMG with the proposed protocol, is able to detect the neuro-modulated 
reflex component of hypertonia as well as the effect induced by BoNT-A injection.  
These results were widely expected and and confirm previous published studies 
(Marinelli 2013). 
Also MAS scores consistently decreased after BoNT-A injection, nevertheless, no 
correlation between MAS values and muscular stiffness as assessed with SWE has 
been found in this study. This absence of correlation can be probably attributed to the 
many limitations of MAS because of its inability to distinguish between intrinsic and 
neural-mediated hypertonus and subjective interpretation of muscle resistance. 
 
Second, SWE showed capability to differentiate paretic from non-paretic muscles. 
Statistically significant differences emerged between velocities detected on paretic 
muscles and respective contralateral ones, in particular SW speeds from paretic 




Such finding was detected both with shortened and passively stretched position of 
different muscles; in the former condition it may be related to the main contribution 
of structural (fibrotic involution) changes; in the latter condition spastic dystonia and 
stretch reflex in paretic muscle should play a pivotal role. 
Further, the greater reduction of SW speeds detected at T1 in stretched muscles, in 
respect to shortened ones, was an expected finding due to the exclusive effect of 
BoNT-A on hypertonic stretch reflex. 
Conversely, in non-paretic muscles SW velocities do not significantly modify 
between the two time points T0-T1 (apart from a minimum change in group B): this 
was a crucial finding which indirectly reinforce data resulted from paretic muscles. 
The minimum change detected in group B could not be easily explained, it may be 
argued the development of a ‘general’ muscular relaxation after BoNT-A injection 
involving also contralateral muscles possibly related to the reduction of hypertonus 
and pain on paretic muscle. 
Kesikburun in 2015 found that stiffness measured with sonoelastography was 
increased in the gastrocnemius muscle on the affected side compared to the 
unaffected side in subjects with unilateral stroke. Some other authors (Gao 2018; 
Mathevon 2018; Rasool 2018) did not show a significant difference between the 
paretic and non-paretic limbs; otherwise, they showed difference between limbs and 
control groups supporting the fact that spastic muscles tend to have greater SW speed 
than non-spastic ones. 
 
The link between the time of the onset of the stroke and the SW speed values has 
been shown in three studies (Lee et al., 2015; Lee et al., 2019; Wu et al., 2017).  
The lack of correlation resulted in this study between time since stroke and the 
stiffness of paretic muscle could be probably due to the heterogeneity of stroke’s 
sequelae, age, lifestyles and rehabilitation programs but, mainly, to the fact that 




Conversely, good correlation emerged between time since stroke and MHS values 
reflecting involutive structural changes occurring to paretic muscles over time and 
detectable with conventional US.  
Further, MHS values showed positive correlation with SWE measurements reflecting 
the role of structural involutive changes in muscle architecture in the development of 
spasticity and its direct connection with viscoelastic properties of paretic muscles. 
As expected, MHS scores did not modify between T0 and T1 confirming that BoNT-
A has no effect on structural fibrotic changes of paretic muscle, at least after a single 
injection.  
This study had some limitations. The first limit of the study was that SWE 
measurements were obtained only by one US-experienced operator: ultrasound 
elastography has the same issues of ultrasonography, which is operator dependent, 
and, to date it lacks a standardization of the methods (Creze 2018, Eby 2016, Lehoux 
2020, Shin 2016). Even if several studies report good reliability of SWE in the 
assessment of skeletal muscle stiffness (Phan 2019, Sarabon 2019, Creze 2018), 
giving the technical difficulties SWE requires to be properly performed, less 
experienced examiners could not achieve the same results. Further, all SWE 
measurement were conducted with a single US equipment: this could have been a 
limitation in particular considering that different manufacturers implemented his own 
algorithms and post-processing calculation to assess mechanical properties 
quantifying the shear wave speed. Since electromyographic and SWE assessments 
have been performed in different sessions and environmental conditions, we cannot 
be sure that patients reached the same level of muscle relaxation/contraction during 
the two measures: this could have been a further limitation of the study. Last, the 
number of patients enrolled in the study was relatively small. Therefore, future 
studies assessing different muscle groups in a larger population with post-stroke 





























This is the first study evaluating the effect of BoNT-A on muscle spasticity following 
stroke by mean of SWE and with the comparison of sEMG data.  
We demonstrated a reduction of muscular stiffness and spasticity, all related to 
neural-mediated hypertonus decrease. In particular, we demonstrated that, in trained 
hands and with a positioning of the probe along the direction of muscular fibers, 
SWE is effective for the assessment of  stiffness decrease after BoNT-A therapy. 
Nevertheless, stretch reflex assessed by sEMG improves more than SWE-assessed 
muscular stiffness because this last technique also encompasses in its measurements 
the structural involutive changes of paretic muscles other than neural-mediated 
spasticity. At T0 in non-stretched conditions when electromyographic activity is 
reduced and, moreover at T1 when botulinum toxin treatment abolishes spasticity and 
spastic dystonia, SWE driven comparison between the spastic muscle and the 
contralateral unaffected homologous one may disclose the amount of stiffness due 
only to intrinsic muscular involutive remodelling. 
Alongside sEMG, shear wave elastography could therefore constitute an added-value 
to clinicians who manage spasticity for the assessment of responses to treatments and 
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spring-shaped gure shown in the left bottom of both the elastograms 
indicates that the pressure the operator performed with the transducer was 
appropriate to produce an adequate stress to get the elastogram. 
 
Fig. 10. Shear wave elastography. The focused US beam pushed by the 
US probe  generates shear waves into the target tissue (left); their 
velocities are detected by the same transducer and represented on the B-
mode image (right) by a superimposed colour-coded map in which (in this 
case) the lower values are depicted in blue and the higher ones in red, 
giving a quantitative analysis of tissutal stiffness (higher speeds in stiffer 
tissues and viceversa). 
 
Fig. 11. SWE of rectus femoris muscle. After the generation of the 
‘pushing’ beam by the transducer, the values of the shear modulus in the 
targeted area are represented by mean of a colour-coded map set as 
represented by the coloured bar on the left of the screen. It is possible to 
get also a quantitative analysis of the investigated tissue by placing some 
ROIs (with modificable dimensions) over the map and get the 
corresponding value at the left bottom angle of the screen. Note that, on 
the right elastographic map, the stiffer areas in the centre of the map 
correspond to the central rectus femoris aponeurosis. 
 
Fig. 12. SWE assessment with transverse orientation of the probe. Scheme 
illustrating SWE acquisition on short axis of muscular fibers: the 
transducer is placed on muscular belly performing consecutive transverse 
scans with the aim of assess the maximum amount of muscle (left); in each 
scan SW velocities are measured in the positioned ROI generating the 
relative color-coded elastogram superimposed to the B-mode image 
(right). A final mean value is then expressed. 
 
Fig. 13. SWE assessment with longitudinal orientation of the probe. 
Scheme illustrating SWE acquisition on long axis of muscular fibers: the 
transducer is placed on muscular belly performing consecutive 
longitudinal scans with the aim of assess the maximum amount of muscle 
(left); in each scan SW velocities are measured in the positioned ROI 
generating the relative color-coded elastogram superimposed to the B-





Fig. 14. Modified Heckmatt scale. Normal background echogenicity with 
clearly internal septa (I); increase in background echogenicity while 
intramuscular septa are still definable (II); 3. increase in background 
echogenicity and less definable septa (III); increase in background 
echogenicity without definable septa (IV).  
 
Fig. 15. sEMG results. Chart illustrating the electromyographic activity 
(μV) measured in spastic muscles before (T0) and 4 weeks after (T1) 
botulinum toxin A injection at muscle relaxation (spastic dystonia) and 
during passive extension (spasticity). 
 
Fig. 16. MAS scores. Chart illustrating the significant difference in MAS 
scores assessments of spastic muscles before (T0) and 4 weeks after (T1) 
botulinum toxin A injection. 
 
Fig. 17. SWE reduction between T0 and T1. In the upper-right quadrant is 
illustrated an example of an elastogram (superimposed to the B-mode 
image) generated by a ROI placed in biceps brachii muscular belly along 
the direction of the fibers at T0; in the lower right image the same 
evaluation at T1 shows lower values (lower left corners of the images). 
Images on the upper- and lower-left quadrant are the correspective B-
mode conventional US image automatically paired on the screen by the 
SEL software. 
 
Fig. 18. SWE difference between transverse and longitudinal assessments. 
In the upper-right quadrant is illustrated an example of an elastogram 
(superimposed to the B-mode image) generated by a ROI placed in a non-
paretic, non-stretched biceps brachii muscular belly across the direction of 
the fibers; in the lower right image the elastogram generated along the 
direction of muscular fibers of the same muscle shows higher values 
expressed both qualitatively with different-coloured map  and 
quantitatively in m/s (lower left corners of the images). Images on the 
upper- and lower-left quadrant are the correspective B-mode conventional 
US image automatically paired on the screen by the SEL software 
(transverse US scan in the upper-left quadrant and longitudinal US scan in 





Fig. 19. Spastic muscles SWE speeds. Chart illustrating SWE velocities 
assessed in paretic muscles at T0 and T1; significant difference (p<0.05) 
found in longitudinal assessments (group Bp and Dp). 
 
Fig. 20. Non-paretic muscles SWE speeds. Chart illustrating SWE 
velocities assessed in non-paretic muscles at T0 and T1; only a slight 
significant difference (p:0.04) found in group B. 
 
Fig.  21. MHS grade II. Conventional US appearance of biceps brachii and 
brachial muscles on non-paretic (NP) and paretic side (P) following stroke: 
on the left image normal US appearance of muscle with regular 
echogenicity of fibers and normal muscular fibers - intrasmuscular septa 
differentiation; the right image shows volume reduction of muscle and 
increase in background echogenicity with intramuscular septa more 
represented but still well definable. 
 
Fig.  22. MHS grade III. Conventional US appearance of biceps brachii 
and brachial muscles on non-paretic (NP) and paretic side (P) following 
stroke, as assessed with longitudinal US scans: on the left image normal 
US appearance of muscle with regular echogenicity of fibers and normal 
muscular fibers - intrasmuscular septa differentiation; the right image 
shows volume reduction of muscle and significant increase in background 
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